Why America Doesn’t Trust the CDC

Why America Doesn’t Trust the CDC

Most remarkably, it didn’t seem to matter to the CDC that 75.2 percent of children under age 11 already have natural immunity, according to a CDC study that concluded in February. Natural immunity is certainly much more prevalent today, given the ubiquity of the Omicron variant since February. CDC data from New York and California demonstrated that natural immunity was 2.8 times more effective in preventing hospitalization and 3.3 to 4.7 times more effective in preventing COVID infection compared to vaccination during the Delta wave. These findings are consistent with dozens of other clinical studies. Yet natural immunity has consistently and inexplicably been dismissed by the medical establishment.

Public health officials are expected to recommend COVID vaccines for children under 5 as soon as June 21st, despite the fact that the vast majority of children already have natural immunity. In a recent Kaiser survey, only 18 percent of parents said they were eager to vaccinate their child in that age group.

Research suggests that vaccination against COVID via mRNA vaccines may reduce body’s ability to produce key type of antibody.

https://www.israelnationalnews.com/news/328102

Vaccines against the coronavirus may impair the body’s ability to produce a key type of antibody, thus potentially limiting the immune system’s defenses against mutated strains of the virus, a new study suggests.

Research suggests that vaccination against COVID via mRNA vaccines may reduce body’s ability to produce key type of antibody.

Rat Out Your Doctor: Biden’s Surgeon General Calls on Informants to Report Use of Generic Drugs

Rat Out Your Doctor: Biden’s Surgeon General Calls on Informants to Report Use of Generic Drugs

The purpose of the RFI is described as being to help the authorities understand the effect of pandemic “misinformation” on such areas as “health decisions and outcomes, direct and indirect costs, trust in the healthcare system and providers, and healthcare worker morale and safety. It is also intended to help them ascertain its impact on “access to trusted and credible health information, particularly during a public health emergency” and on “lifesaving health decisions such as an individual’s likelihood to vaccinate, and to “prepare for and respond to future public health crises.”

The RFI, which covers a period extending from January 2020 to the present, applies to general search engines, content sharing platforms, social media platforms, e-commerce platforms, crowd-sourced platforms, and instant messaging systems, and includes “research, case studies, data sets, images, data visualizations, interviews, and personal testimonies.”

UPDATED: FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant

FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant

Related:

WSJ: FDA Eyes Second Covid-19 Booster Shot

A fourth booster shot of either the Pfizer or Moderna vaccine could start an annual booster shot campaign, one of the people familiar with the FDA’s planning said.

I’m not buying the media’s scaremongering about the second omicron variant!

Various Coronavirus News Updates: U.S. National Emergency extended, Bill Gates disappointed, IVM, breakthrough cases, immunity + antibodies.

Biden to extend U.S. national emergency due to COVID-19 health risk

Bill Gates is Ready to Capitalize on ‘The Next Pandemic’

Estimated 73% of US now immune to omicron: Is that enough?

Arkansas county praises doctor who gave inmates ivermectin

2,044 Fully Vaccinated Indiana Residents Died Of COVID-19; 329,000 Breakthrough Cases Recorded

A test to determine COVID immunity could reshape US policy

I’m behind because I haven’t really been keeping up with coronavirus news. Out of sight, out of mind! 🤷🏼‍♀️

J&J pauses production of its Covid-19 vaccine despite persistent need 💰

J&J pauses production of its Covid-19 vaccine despite persistent need

The facility, in the Dutch city of Leiden, has instead been making an experimental but potentially more profitable vaccine to protect against an unrelated virus.

But poorer countries remain reliant on Johnson & Johnson’s vaccine, which does not require ultracold refrigeration. It has been shown to provide strong and long-lasting protection against severe disease across variants, including omicron, when given as a two-shot regimen. As a single shot, the vaccine is less expensive and relatively easy to give to hard-to-reach populations.

Unlike companies such as Pfizer and Moderna, which have reaped billions of dollars in profits, Johnson & Johnson did not find the COVID vaccine to be a big moneymaker.

….

Since production of the COVID vaccine was halted late last year, the Netherlands plant has been manufacturing an experimental vaccine against respiratory syncytial virus, or RSV, that will be used for a clinical trial in older adults in wealthy countries, a person familiar with the matter said. Even if it proves effective, the vaccine is not expected to become available for several years.

Omicron pioneer Dr Angelique Coetzee pressured by world powers to exaggerate its seriousness

Omicron pioneer Dr Angelique Coetzee pressured by world powers to exaggerate its seriousness

“But I have stated many times before it can be a serious illness if you are unvaccinated and have comorbidities but for the majority of people it is a mild illness. I am the one who has seen the patients first-hand but the politicians won’t listen.”

Related:

Video source: The Jimmy Dore Show on YouTube